BFC Planning’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$261K Sell
3,483
-1,796
-34% -$142K 0.01% 840
2026
Q2
$417K Sell
5,279
-1,117
-17% -$94.9K 0.02% 670
2026
Q1
$551K Buy
6,396
+6,378
+35,433% +$572K 0.02% 534
2025
Q4
$1.57K Hold
18
– – ﹤0.01% 2697
2025
Q3
$1.03K Sell
18
-14
-44% -$806 ﹤0.01% 2622
2025
Q2
$1.89K Sell
32
-3,540
-99% -$229K ﹤0.01% 2321
2025
Q1
$261K Buy
+3,572
New +$295K 0.02% 519

Other funds holding GMED

BFC Planning's GMED Position: Q3 2026 in Review

BFC Planning reduced its Globus Medical (GMED) stake by 34% in Q3 2026, selling an estimated $142K and leaving 3,483 shares worth $261K. The position accounts for 0.01% of the portfolio, ranked #840.

BFC Planning first reported a position in GMED in Q1 2025 and has held it in 7 quarters since. The position peaked at $551K in Q1 2026. 513 funds tracked by Wall St. Rank hold GMED as of Q3 2026.

  • BFC Planning held 3,483 shares of Globus Medical worth $261K as of Q3 2026.
  • BFC Planning sold 1,796 Globus Medical shares in Q3 2026, an estimated $142K.
  • Globus Medical made up 0.01% of BFC Planning's portfolio in Q3 2026, its #840 holding.
  • BFC Planning first reported a position in Globus Medical in Q1 2025 and has held it in 7 quarters since.
  • BFC Planning's Globus Medical position peaked at $551K in Q1 2026.
  • 513 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.